Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-13

FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Archis Pharma LLC)

View source ↗

Summary

FDA approved Archis Pharma LLC's supplemental application for Mycophenolic acid, enabling the continued marketing of this product under an approved supplement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mycophenolic acid (mycophenolic acid)

Snippet

SUPPL AP for MYCOPHENOLIC ACID (MYCOPHENILIC ACID)